Department of Surgical Sciences, University of Turin, Turin, Italy.
Surg Endosc. 2013 May;27(5):1485-502. doi: 10.1007/s00464-012-2649-x. Epub 2012 Nov 25.
Although definitive long-term results are not yet available, the global safety of laparoscopic surgery for rectal cancer treatment remains controversial. We evaluated differences in the safety of laparoscopic rectal resection versus open surgery for cancer.
A systematic review from 2000 to 2011 was performed searching the Medline and Embase databases (prospero registration CRD42012002406). We included randomized and prospective controlled clinical studies comparing laparoscopic and open resection for rectal cancer. Primary end points were 30-day mortality and overall morbidity. Then a meta-analysis was conducted by a fixed-effect model, performing a sensitivity analysis by a random-effect model. Relative risk (RR) was used as an indicator of treatment effect; a RR of less than 1.0 was in favor of laparoscopy. Publication bias was assessed by funnel plot and heterogeneity by the I (2) test and subgroup analysis on surgical and medical complications.
Twenty-three studies, representing 4,539 patients, met the inclusion criteria; eight were randomized for a total of 1,746 patients. Mortality was observed in 1.0 % of patients in the laparoscopic group and in 2.4 % of patients in the open group. The overall RR was 0.46 (95 % confidence interval 0.21-0.99, p = 0.048). The raw incidence of overall complications was lower in the laparoscopic group (31.8 %) compared to the open group (35.4 %). The overall RR was 0.83 (95 % confidence interval 0.76-0.91, p < 0.001).
On the basis of evidence of both randomized and prospective controlled series, mortality and morbidity RR, including subgroup analysis, were significantly lower after laparoscopic compared to open surgery.
虽然尚无明确的长期结果,但腹腔镜直肠癌治疗的全球安全性仍存在争议。我们评估了腹腔镜直肠切除术与开腹手术治疗癌症的安全性差异。
从 2000 年至 2011 年进行了系统评价,检索了 Medline 和 Embase 数据库(prospero 注册号 CRD42012002406)。我们纳入了比较腹腔镜和开腹直肠癌切除术的随机和前瞻性对照临床试验。主要终点是 30 天死亡率和总发病率。然后通过固定效应模型进行荟萃分析,并通过随机效应模型进行敏感性分析。相对风险(RR)用作治疗效果的指标;RR 小于 1.0 有利于腹腔镜手术。通过漏斗图评估发表偏倚,并通过 I 2 检验和手术及医疗并发症的亚组分析评估异质性。
23 项研究,共 4539 例患者符合纳入标准;其中 8 项为随机对照研究,共 1746 例患者。腹腔镜组患者死亡率为 1.0%,开腹组患者死亡率为 2.4%。总的 RR 为 0.46(95%置信区间 0.21-0.99,p=0.048)。腹腔镜组总体并发症发生率(31.8%)低于开腹组(35.4%)。总的 RR 为 0.83(95%置信区间 0.76-0.91,p<0.001)。
基于随机和前瞻性对照系列的证据,包括亚组分析,腹腔镜与开腹手术相比,死亡率和发病率 RR 显著降低。